Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MICHELLE L SLAVIN

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1619499274
CMS profile
10842102
Location
SOUTHINGTON, CT

General Payments · PY2023–2024

$1,255.56

  • Reported across 28 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$554.20

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $554.20 15

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Xeris Pharmaceuticals, Inc. $217.16 6
CeQur Corporation $104.62 1
DEXCOM, INC. $95.24 1
Abbott Laboratories $58.20 3
Medtronic, Inc. $43.09 2
Insulet Corporation $21.81 1
Novo Nordisk AS $14.08 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2023 $701.36 13
PY2024 $554.20 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $18.60 03/29/2024 Food and Beverage Undisputed 01/23/2026 1125155743 CMS
Abbott Laboratories $21.61 04/30/2024 Food and Beverage Undisputed 01/23/2026 1125155745 CMS
Abbott Laboratories $17.99 07/08/2024 Food and Beverage Undisputed 01/23/2026 1125155747 CMS
CeQur Corporation $104.62 07/17/2024 Food and Beverage Undisputed 01/23/2026 1099650099 CMS
Dexcom, Inc. $95.24 12/19/2024 Food and Beverage Undisputed 01/23/2026 1153379778 CMS
Insulet Corporation $21.81 02/28/2024 Food and Beverage Undisputed 01/23/2026 1116797539 CMS
Medtronic, Inc. $17.84 04/02/2024 Food and Beverage Undisputed 01/23/2026 1116969321 CMS
Medtronic, Inc. $25.25 11/14/2024 Food and Beverage Undisputed 01/23/2026 1116969323 CMS
Novo Nordisk Inc $14.08 11/21/2024 Food and Beverage Undisputed 01/23/2026 1100323248 CMS
Xeris Pharmaceuticals, Inc. $23.15 05/10/2024 Food and Beverage Undisputed 01/23/2026 1144635420 CMS
Xeris Pharmaceuticals, Inc. $124.99 09/19/2024 Food and Beverage Undisputed 01/23/2026 1144635422 CMS
Xeris Pharmaceuticals, Inc. $12.79 09/27/2024 Food and Beverage Undisputed 01/23/2026 1144635418 CMS
Xeris Pharmaceuticals, Inc. $23.44 10/28/2024 Food and Beverage Undisputed 01/23/2026 1144635424 CMS
Xeris Pharmaceuticals, Inc. $21.89 11/27/2024 Food and Beverage Undisputed 01/23/2026 1144635428 CMS
Xeris Pharmaceuticals, Inc. $10.90 12/23/2024 Food and Beverage Undisputed 01/23/2026 1144635426 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2023, 2024
Source files
Dataset page · Bulk file · PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.